First UK patients treated for liver cancer using ultrasound technology

Two patients have become the first in the UK to undergo a pioneering new treatment for liver cancer as part of a US-based study.

The HistoSonics’ #HOPE4LIVER study forms a partnership between St James’s Hospital - which is managed by Leeds Teaching Hospitals NHS Trust – and the Freeman Hospital in Newcastle.

Sheila Riley, 68 from Bradford and another patient from Newcastle received the treatment which uses the novel science of histotripsy.

The treatment is a form of therapeutic focused ultrasound, to destroy targeted primary and metastatic liver tumours without the need for invasive incisions or needles entering the patient’s body.

The treatment in Leeds took a record-breaking six minutes and 58 seconds to complete. 

The first treatment using the new technology by HistoSonics was undertaken at a Florida hospital in February 2021 with a patient in Germany subsequently becoming the first in Europe.

Leeds Teaching Hospitals Trust is the first location in the UK to enrol patients in the #HOPE4LIVER study and is working in collaboration with Newcastle Hospitals NHS Foundation Trust to deliver the treatment to patients in Leeds and Newcastle.

It is hoped that following a successful trial, that this new method of treatment will become available more widely for eligible patients in the UK. 

Dr Tze Min Wah, Senior Consultant Radiologist in Diagnostic and Interventional Radiology at Leeds Teaching Hospitals Trust, who is leading the #HOPE4LIVER trial in Leeds, said: “It is exciting to be given this opportunity to lead this pioneering trial using histotripsy to treat liver cancer.

“This is the first ‘surgical’ treatment of liver cancer that requires no needles or scalpels.

“In addition, this procedure also involves no radiation.

“There is a real potential to truly shift the paradigm of liver cancer treatment in the future with this innovative technology and further potential for translation into cancer treatment of other sites.” 

Dr Peter Littler, Consultant Interventional Radiologist at the Freeman Hospital in Newcastle said: “This is fascinating cutting-edge technology with the potential to kill a liver cancer without breaking the skin. 

“It was very exciting for our team to deliver the first treatment in the UK. It is a pleasure to work with colleagues in Leeds to offer this treatment to our patients as part of the HOPE4LIVER trial.” 

NHE June-July 2022

NHE May/June 22

Is AI the Future?

The new edition of NHE’s e-magazine highlights the latest innovations making the NHS more environmentally friendly; the health sector’s digital transformation journey; the latest advancements in procurement, how to stay safe in the current climate, and more with articles from the likes of Dame Linda Pollard, Professor Sir Stephen Holgate, Brigadier Robin Simpson and many more.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all